Search details
1.
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study.
Eur J Clin Microbiol Infect Dis
; 42(7): 843-852, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37133639
2.
Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment.
Eur J Clin Microbiol Infect Dis
; 40(1): 219-224, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32729059
3.
In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.
J Antimicrob Chemother
; 75(8): 2164-2172, 2020 08 01.
Article
in English
| MEDLINE | ID: mdl-32449909
4.
Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019.
Euro Surveill
; 25(3)2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31992391
5.
Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016.
Euro Surveill
; 23(31)2018 08.
Article
in English
| MEDLINE | ID: mdl-30086819
6.
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies.
Expert Rev Anti Infect Ther
; 20(1): 53-69, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34033499
7.
Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
J Glob Antimicrob Resist
; 20: 98-104, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31398495
Results
1 -
7
de 7
1
Next >
>>